The free-of-charge event strives to get the widest audience possible from health and medicines R&D together.
Taking place on Tuesday, 10th November, the theme for this year’s event is ‘Broader horizons: growing Europe’s health partnership’.
Sure to be an interesting online event, it will focus on pediatric cancers and demonstrate how a new partnership will bring stakeholders together, synergizing with the Cancer Mission to be more inclusive in the co-creation of ideas for the program.
The free-of-charge event strives to get the widest audience possible from health and medicines R&D together. Aimed at policymakers, academics, pharmaceutical/ medical technology industries, patient representatives, regulators, and health NGOs, it’s set to discuss ideas to help develop the new partnership, avoid pitfalls and build together a world-leading collaboration.
The event will include leaders in both policymaking and science and technology, and feature a closing speech from Member of the European Parliament Maria Da Graça Carvalho; perfectly demonstrating the Innovative Medicines Initiative (IMI) public-private partnership between the EU and EFPIA – European Federation of Pharmaceutical Industries and Associations.
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency